CN1398585A - 一种bFGF-PLA-PEG缓释微球及其制备方法和用途 - Google Patents
一种bFGF-PLA-PEG缓释微球及其制备方法和用途 Download PDFInfo
- Publication number
- CN1398585A CN1398585A CN 02133477 CN02133477A CN1398585A CN 1398585 A CN1398585 A CN 1398585A CN 02133477 CN02133477 CN 02133477 CN 02133477 A CN02133477 A CN 02133477A CN 1398585 A CN1398585 A CN 1398585A
- Authority
- CN
- China
- Prior art keywords
- bfgf
- peg
- microsphere
- pla
- slow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011806 microball Substances 0.000 title 1
- 239000004005 microsphere Substances 0.000 claims abstract description 37
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 34
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 8
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 4
- 239000011159 matrix material Substances 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 57
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 238000013268 sustained release Methods 0.000 claims description 11
- 239000012730 sustained-release form Substances 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 8
- 239000012071 phase Substances 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 210000003022 colostrum Anatomy 0.000 claims description 3
- 235000021277 colostrum Nutrition 0.000 claims description 3
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims 2
- 229920000151 polyglycol Polymers 0.000 claims 1
- 239000010695 polyglycol Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 229920001577 copolymer Polymers 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000008020 evaporation Effects 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- 238000010907 mechanical stirring Methods 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 description 16
- 239000000463 material Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002491 angiogenic effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000003226 mitogen Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- -1 L-lactic acid-Polyethylene Chemical group 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02133477 CN1398585A (zh) | 2002-07-15 | 2002-07-15 | 一种bFGF-PLA-PEG缓释微球及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02133477 CN1398585A (zh) | 2002-07-15 | 2002-07-15 | 一种bFGF-PLA-PEG缓释微球及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1398585A true CN1398585A (zh) | 2003-02-26 |
Family
ID=4747215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02133477 Pending CN1398585A (zh) | 2002-07-15 | 2002-07-15 | 一种bFGF-PLA-PEG缓释微球及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1398585A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100400032C (zh) * | 2004-09-16 | 2008-07-09 | 同济大学 | 一种油溶性药物缓释微球的制备方法 |
CN103143065A (zh) * | 2013-03-19 | 2013-06-12 | 四川大学 | 一种具有多生长因子次第释放特性的组织工程支架 |
US8518429B2 (en) | 2007-11-27 | 2013-08-27 | Beijing Amsino Medical Co., Ltd. | Arsenic trioxide medical elution scaffold |
CN103611186A (zh) * | 2013-12-02 | 2014-03-05 | 李夏林 | 缓释活性因子pela微球支架骨修复材料的制备方法 |
CN104114159A (zh) * | 2011-12-14 | 2014-10-22 | 阿布拉科斯生物科学有限公司 | 用于颗粒冻干或冷冻的聚合物赋形剂 |
CN103611186B (zh) * | 2013-12-02 | 2016-11-30 | 李夏林 | 缓释活性因子pela微球支架骨修复材料的制备方法 |
CN108324928A (zh) * | 2018-03-05 | 2018-07-27 | 哈尔滨医科大学 | 重组人成纤维细胞生长因子-5在促骨折愈合中的应用 |
US11156119B2 (en) | 2015-06-23 | 2021-10-26 | General Electric Company | Relative position measurement |
CN114522220A (zh) * | 2020-11-06 | 2022-05-24 | 珠海亿胜生物制药有限公司 | 一种碱性成纤维细胞生长因子微球及其制备方法 |
-
2002
- 2002-07-15 CN CN 02133477 patent/CN1398585A/zh active Pending
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100400032C (zh) * | 2004-09-16 | 2008-07-09 | 同济大学 | 一种油溶性药物缓释微球的制备方法 |
US8518429B2 (en) | 2007-11-27 | 2013-08-27 | Beijing Amsino Medical Co., Ltd. | Arsenic trioxide medical elution scaffold |
CN109771377A (zh) * | 2011-12-14 | 2019-05-21 | 阿布拉科斯生物科学有限公司 | 用于颗粒冻干或冷冻的聚合物赋形剂 |
US10555912B2 (en) | 2011-12-14 | 2020-02-11 | Abraxis Bioscience, Llc | Use of polymeric excipients for lyophilization or freezing of particles |
EP3560486A1 (en) * | 2011-12-14 | 2019-10-30 | Abraxis BioScience, LLC | Use of polymeric excipients for lyophilization or freezing of particles |
CN104114159A (zh) * | 2011-12-14 | 2014-10-22 | 阿布拉科斯生物科学有限公司 | 用于颗粒冻干或冷冻的聚合物赋形剂 |
EP2790675A4 (en) * | 2011-12-14 | 2015-05-06 | Abraxis Bioscience Llc | USE OF POLYMERIC EXCIPIENTS FOR LYOPHILIZATION OR FREEZING PARTICLES |
CN104114159B (zh) * | 2011-12-14 | 2019-08-09 | 阿布拉科斯生物科学有限公司 | 用于颗粒冻干或冷冻的聚合物赋形剂 |
US9585960B2 (en) | 2011-12-14 | 2017-03-07 | Abraxis Bioscience, Llc | Use of polymeric excipients for lyophilization or freezing of particles |
AU2012352167B2 (en) * | 2011-12-14 | 2017-07-27 | Abraxis Bioscience, Llc | Use of polymeric excipients for lyophilization or freezing of particles |
AU2017239541B2 (en) * | 2011-12-14 | 2019-07-04 | Abraxis Bioscience, Llc | Use of polymeric excipients for lyophilization or freezing of particles |
US10076501B2 (en) | 2011-12-14 | 2018-09-18 | Abraxis Bioscience, Llc | Use of polymeric excipients for lyophilization or freezing of particles |
CN103143065B (zh) * | 2013-03-19 | 2015-01-28 | 四川大学 | 一种具有多生长因子次第释放特性的组织工程支架 |
CN103143065A (zh) * | 2013-03-19 | 2013-06-12 | 四川大学 | 一种具有多生长因子次第释放特性的组织工程支架 |
CN103611186B (zh) * | 2013-12-02 | 2016-11-30 | 李夏林 | 缓释活性因子pela微球支架骨修复材料的制备方法 |
CN103611186A (zh) * | 2013-12-02 | 2014-03-05 | 李夏林 | 缓释活性因子pela微球支架骨修复材料的制备方法 |
US11156119B2 (en) | 2015-06-23 | 2021-10-26 | General Electric Company | Relative position measurement |
CN108324928A (zh) * | 2018-03-05 | 2018-07-27 | 哈尔滨医科大学 | 重组人成纤维细胞生长因子-5在促骨折愈合中的应用 |
CN108324928B (zh) * | 2018-03-05 | 2020-09-08 | 哈尔滨医科大学 | 重组人成纤维细胞生长因子-5在促骨折愈合中的应用 |
CN114522220A (zh) * | 2020-11-06 | 2022-05-24 | 珠海亿胜生物制药有限公司 | 一种碱性成纤维细胞生长因子微球及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aguilar et al. | Growth factor delivery: Defining the next generation platforms for tissue engineering | |
Tan et al. | Development of alginate-based hydrogels: Crosslinking strategies and biomedical applications | |
Sun et al. | Engineering dextran-based scaffolds for drug delivery and tissue repair | |
Jay et al. | Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation | |
Chen et al. | A self-healing, magnetic and injectable biopolymer hydrogel generated by dual cross-linking for drug delivery and bone repair | |
Wu et al. | Engineering bioresponsive hydrogels toward healthcare applications | |
CN105879123B (zh) | Plga纤维-微球双载药复合支架及其制备方法 | |
Ruan et al. | Progress in the application of sustained-release drug microspheres in tissue engineering | |
CN1398584A (zh) | 一种bFGF-PLGA缓释微球及其制备方法和用途 | |
CN104470505B (zh) | 微球组合物及其制备方法和应用 | |
CN101658497B (zh) | 一种双重载药的复合微球及其制备方法 | |
JP2016509610A (ja) | 鎖延長されたポロキサマー、生物材料を含むそれから形成された熱可逆性ハイドロゲルおよびその医学的適用 | |
CN103877621B (zh) | 一种电纺纤维增强磷酸钙骨水泥复合材料及其应用 | |
WO2011059112A1 (ja) | 粒子含有細胞集合体 | |
CN103330680A (zh) | 纳米药物透皮制剂及其制备方法 | |
Wu et al. | Stem cell niche-inspired microcarriers with ADSCs encapsulation for diabetic wound treatment | |
TW201247179A (en) | Polyelectrolyte complex gels and soft tissue augmentation implants comprising the same | |
CN1398585A (zh) | 一种bFGF-PLA-PEG缓释微球及其制备方法和用途 | |
CN1903939A (zh) | 载有蛋白大分子的多糖-聚合物及其制备方法 | |
CN1887274A (zh) | 蛋白质-多糖玻璃体微粒缓释微球的制备方法 | |
Mu et al. | Biomaterials‐based cell therapy for myocardial tissue regeneration | |
Zhai et al. | Gelatin-based targeted delivery systems for tissue engineering | |
Fischbach et al. | Polymeric systems for bioinspired delivery of angiogenic molecules | |
Chew et al. | Bioresorbable polymer microparticles in the medical and pharmaceutical fields | |
CN101816634B (zh) | 超声雾化法制备载骨生长因子微球技术 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: DUAN HONG CHEN JIAN Effective date: 20050415 Owner name: HUAXI HOSPITAL ATTACHED TO SICHUAN UNIV. Free format text: FORMER OWNER: PEI FUXING |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050415 Address after: No.37 Guoxue Lane, West China Hospital of Sichuan University, Chengdu, Sichuan Province Applicant after: WEST CHINA HOSPITAL OF SICHUAN University Address before: No. three, South Renmin Road, Sichuan, Chengdu province 17 Applicant before: Pei Fuxing Co-applicant before: Duan Hong Co-applicant before: Chen Jian |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |